Mesa Labs launches restructuring plan to cut annualized operating costs by about $9.3 million
MLAB•Mesa Laboratories launched a plan targeting about $9.3 million in annualized operating cost cuts, with about $4.3 million reinvested for growth and a net annualized reduction of about $5 million. The plan includes eliminating about 40 roles and exiting its Hamburg facility when its lease ends in February 2027.
1. Restructuring targets
Mesa Laboratories launched a restructuring and savings plan targeting about $9.3 million in annualized operating cost cuts. About $4.3 million of the savings will be reinvested for growth, leaving a net annualized cost reduction of about $5 million.
2. Workforce and operations
The plan includes eliminating about 40 roles, or about 6% of headcount, with limited impact on manufacturing operations. Cost cuts will concentrate in Clinical Genomics, which will be managed for profitability with lower revenue expected. The company plans to exit its Hamburg facility when its lease ends in February 2027, and expects actions to be largely complete by fiscal 2027.
